White label ELPA - ClinicalTrials.eu

Study on the Effects of Cerebrolysin and Sodium Chloride for Recovery in Patients with Moderate to Severe Traumatic Brain Injury

Recruiting

3 1 1 1
Investigated diseases:
- Craniocerebral injury
Investigated drugs:
- Cerebrolysin Concentrate
- Sodium Chloride
Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

Recruiting

3 1 1 1
Investigated drugs:
+6
Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Recruiting

3 1 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
- Pembrolizumab
- Petosemtamab
+8
Study on Continuing or Stopping Imatinib in Patients with Advanced or Metastatic Gastrointestinal Stromal Tumors After 10 Years of Treatment

Recruiting

2 1 1 1
Investigated diseases:
- Gastrointestinal stromal tumour
Investigated drugs:
- Imatinib Mesilate
Study of azacitidine combined with low-dose venetoclax treatment for patients with acute myeloid leukemia

Recruiting

2 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
Study on the Effectiveness of Dexamethasone Implant for Patients with Diabetic Macular Edema

Recruiting

2 1 1 1
Investigated drugs:
- Dexamethasone
Study on the Effectiveness and Safety of Tocilizumab and Adalimumab for Patients with Severe Uveitis in Behçet’s Disease

Recruiting

2 1 1 1
Investigated diseases:
- Behcet’s syndrome
- Uveitis
Investigated drugs:
- Adalimumab
- Tocilizumab
Study on Proactive Drug Monitoring with Secukinumab, Ixekizumab, or Guselkumab for Patients with Moderate-to-Severe Psoriasis

Recruiting

3 1 1 1
Investigated diseases:
- Psoriasis
Investigated drugs:
Study on Treating Solid Tumors with Genetically Modified T-Cells (IMA203, IMA203CD8) and Nivolumab for Patients with Recurrent or Refractory Conditions

Recruiting

2 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
Study on the Safety and Effects of ION582 for Patients with Angelman Syndrome

Recruiting

2 1 1
Investigated diseases:
- Angelman’s syndrome
Investigated drugs:
- 2′-O-(2-Methoxyethyl) Modified Antisense Oligonucleotide Targeting Ube3A Antisense Transcript Rna

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies